FDA Post-Marketing Safety Decisions
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
The U.S. Food and Drug Administration (FDA) black box warning that antidepressants increase the risk of suicidal thinking and behavior in children was followedby a sharp fall in antidepressant prescriptions. No procedure for estimating the net public health impact exists.1 No suicide occurred in clinical trials of approximately 4400 children, but the term suicidality clearly implies a high degree of lethal risk.’ ‹
J Clin Psychiatry 2006;67(8):1305-1306Related Articles
Quick Links: Psychopharmacology
Buy this Article as a PDF